Dabogratinib (TYRA-300) 60mg
TYR300-203
Phase 2 small_molecule active
Quick answer
Dabogratinib (TYRA-300) 60mg for Low Grade Upper Tract Urothelial Carcinoma is a Phase 2 program (small_molecule) at Tyra Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tyra Biosciences
- Indication
- Low Grade Upper Tract Urothelial Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active